How Can A Company Market An Ovarian Cancer Screening Test If The FDA Says Women Shouldn't Use It?

Blogger's Note: the editorial referenced in this article is not open access/1st page view only (j gynecologic oncology)

Forbes

 ...The FDA’s “safety communication” warned that no currently available test is accurate and reliable for screening women who don’t have symptoms of ovarian cancer. That helps explain why, according to the American Cancer Society , ovarian cancer represents  only 3% of all malignancies in U.S. women but causes more deaths than any other cancer of the female reproductive tract.....